Obesity – significant medical and social problem of our time: risk factors, pathophysiological determinants, treatment strategies. A review

Obesity is a chronic multifactorial recurrent condition with serious health consequences that contributes significantly to the morbidity and mortality in the population. A positive energy balance, which occurs when food is consumed in an amount exceeding the energy consumption or when energy consump...

Full description

Saved in:
Bibliographic Details
Main Author: Elena V. Biryukova
Format: Article
Language:Russian
Published: ZAO "Consilium Medicum" 2024-09-01
Series:Consilium Medicum
Subjects:
Online Access:https://consilium.orscience.ru/2075-1753/article/viewFile/641913/157595
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846166277598478336
author Elena V. Biryukova
author_facet Elena V. Biryukova
author_sort Elena V. Biryukova
collection DOAJ
description Obesity is a chronic multifactorial recurrent condition with serious health consequences that contributes significantly to the morbidity and mortality in the population. A positive energy balance, which occurs when food is consumed in an amount exceeding the energy consumption or when energy consumption is reduced, is considered one of the main mechanisms of obesity. The most common type of obesity is exogenous (alimentary-constitutional). There are various pathophysiological determinants of obesity, with adipose tissue playing the most significant role. Non-pharmacological therapies, including lifestyle changes through nutritional correction and increase in physical activity, behavioral therapies aimed at preventing or treating eating disorders, are recommended as the first, mandatory, and continuous stage of obesity treatment. However, the use of non-pharmacological interventions alone is often limited by insufficient effectiveness. Fonturacetam has a promising potential for use in the fight against obesity. The mechanisms of fonturacetam influence on body weight control, energy homeostasis, carbohydrate and fat metabolism, anorexigenic and anti-inflammatory effects showed in studies are the key factors determining the prospects of fonturacetam use in the complex therapy of obesity.
format Article
id doaj-art-86ffe674494e42cda498e17f90047cab
institution Kabale University
issn 2075-1753
2542-2170
language Russian
publishDate 2024-09-01
publisher ZAO "Consilium Medicum"
record_format Article
series Consilium Medicum
spelling doaj-art-86ffe674494e42cda498e17f90047cab2024-11-15T19:56:53ZrusZAO "Consilium Medicum"Consilium Medicum2075-17532542-21702024-09-0126746146910.26442/20751753.2024.7.2030144881Obesity – significant medical and social problem of our time: risk factors, pathophysiological determinants, treatment strategies. A reviewElena V. Biryukova0https://orcid.org/0000-0001-9007-4123Russian University of MedicineObesity is a chronic multifactorial recurrent condition with serious health consequences that contributes significantly to the morbidity and mortality in the population. A positive energy balance, which occurs when food is consumed in an amount exceeding the energy consumption or when energy consumption is reduced, is considered one of the main mechanisms of obesity. The most common type of obesity is exogenous (alimentary-constitutional). There are various pathophysiological determinants of obesity, with adipose tissue playing the most significant role. Non-pharmacological therapies, including lifestyle changes through nutritional correction and increase in physical activity, behavioral therapies aimed at preventing or treating eating disorders, are recommended as the first, mandatory, and continuous stage of obesity treatment. However, the use of non-pharmacological interventions alone is often limited by insufficient effectiveness. Fonturacetam has a promising potential for use in the fight against obesity. The mechanisms of fonturacetam influence on body weight control, energy homeostasis, carbohydrate and fat metabolism, anorexigenic and anti-inflammatory effects showed in studies are the key factors determining the prospects of fonturacetam use in the complex therapy of obesity.https://consilium.orscience.ru/2075-1753/article/viewFile/641913/157595obesityenergy balanceadipose tissuehypothalamuschronic inflammationneuroinflammationweight losspharmacotherapyfonturacetam
spellingShingle Elena V. Biryukova
Obesity – significant medical and social problem of our time: risk factors, pathophysiological determinants, treatment strategies. A review
Consilium Medicum
obesity
energy balance
adipose tissue
hypothalamus
chronic inflammation
neuroinflammation
weight loss
pharmacotherapy
fonturacetam
title Obesity – significant medical and social problem of our time: risk factors, pathophysiological determinants, treatment strategies. A review
title_full Obesity – significant medical and social problem of our time: risk factors, pathophysiological determinants, treatment strategies. A review
title_fullStr Obesity – significant medical and social problem of our time: risk factors, pathophysiological determinants, treatment strategies. A review
title_full_unstemmed Obesity – significant medical and social problem of our time: risk factors, pathophysiological determinants, treatment strategies. A review
title_short Obesity – significant medical and social problem of our time: risk factors, pathophysiological determinants, treatment strategies. A review
title_sort obesity significant medical and social problem of our time risk factors pathophysiological determinants treatment strategies a review
topic obesity
energy balance
adipose tissue
hypothalamus
chronic inflammation
neuroinflammation
weight loss
pharmacotherapy
fonturacetam
url https://consilium.orscience.ru/2075-1753/article/viewFile/641913/157595
work_keys_str_mv AT elenavbiryukova obesitysignificantmedicalandsocialproblemofourtimeriskfactorspathophysiologicaldeterminantstreatmentstrategiesareview